About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: October 7, 2009
Will Your Company Feel Free to Fully Participate in the Part 15 Meeting on Social Media
I thought it would be interesting to determine, even if unscientifically, whether or not companies felt that they were going to be able to freely participate in the Part 15 FDA meeting on social media, or if there is some … Continue reading
Posted in Uncategorized
Comments Off on Will Your Company Feel Free to Fully Participate in the Part 15 Meeting on Social Media
More Thoughts on the Strategic and Regulatory Implications of Sidewiki
On Monday, the posting on Eye on FDA talked about 3 new tools either introduced or in beta testing by Google – Google Squared, Google Fast Flip and Google Sidewicki. Of the three, Sidewiki has the most strategic and regulatory … Continue reading
Posted in New and Social Media
1 Comment